

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 7.35924843 |
| 2 | cytidine catabolic process (GO:0006216) | 7.35924843 |
| 3 | cytidine deamination (GO:0009972) | 7.35924843 |
| 4 | DNA deamination (GO:0045006) | 6.96419486 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.63602677 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.44495619 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.84970917 |
| 8 | actin nucleation (GO:0045010) | 4.43978673 |
| 9 | negative regulation of T cell apoptotic process (GO:0070233) | 4.32264907 |
| 10 | protein neddylation (GO:0045116) | 4.07435397 |
| 11 | eosinophil chemotaxis (GO:0048245) | 4.00760056 |
| 12 | positive thymic T cell selection (GO:0045059) | 3.99301961 |
| 13 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.92628150 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85940062 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 3.85605466 |
| 16 | regulation of chronic inflammatory response (GO:0002676) | 3.71248091 |
| 17 | negative regulation by host of viral transcription (GO:0043922) | 3.70917319 |
| 18 | regulation of regulatory T cell differentiation (GO:0045589) | 3.69296223 |
| 19 | eosinophil migration (GO:0072677) | 3.61399912 |
| 20 | positive T cell selection (GO:0043368) | 3.57970394 |
| 21 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.57339692 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.56789170 |
| 23 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.53115963 |
| 24 | sequestering of actin monomers (GO:0042989) | 3.48136025 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.43013573 |
| 26 | T cell migration (GO:0072678) | 3.42903805 |
| 27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.42843192 |
| 28 | negative regulation of viral genome replication (GO:0045071) | 3.39879142 |
| 29 | platelet dense granule organization (GO:0060155) | 3.31310434 |
| 30 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.30781732 |
| 31 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.29189379 |
| 32 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.23919699 |
| 33 | positive regulation of defense response to virus by host (GO:0002230) | 3.22949912 |
| 34 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.21419719 |
| 35 | T cell costimulation (GO:0031295) | 3.18879900 |
| 36 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.17213739 |
| 37 | lymphocyte costimulation (GO:0031294) | 3.15393562 |
| 38 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.14920794 |
| 39 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.14920794 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.12043930 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.11665893 |
| 42 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.10746060 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.05889735 |
| 44 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04910759 |
| 45 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.03781368 |
| 46 | granulocyte activation (GO:0036230) | 2.99704322 |
| 47 | regulation of T cell apoptotic process (GO:0070232) | 2.98286660 |
| 48 | macrophage chemotaxis (GO:0048246) | 2.95501585 |
| 49 | B cell mediated immunity (GO:0019724) | 2.94917672 |
| 50 | metallo-sulfur cluster assembly (GO:0031163) | 2.94180121 |
| 51 | iron-sulfur cluster assembly (GO:0016226) | 2.94180121 |
| 52 | regulation of interleukin-8 secretion (GO:2000482) | 2.92573248 |
| 53 | positive regulation of cell killing (GO:0031343) | 2.91824810 |
| 54 | T cell receptor signaling pathway (GO:0050852) | 2.90104278 |
| 55 | mast cell activation (GO:0045576) | 2.89910359 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 2.89645150 |
| 57 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.89114238 |
| 58 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.89056288 |
| 59 | neutrophil activation (GO:0042119) | 2.87753006 |
| 60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.87192019 |
| 61 | positive regulation of T cell apoptotic process (GO:0070234) | 2.85164307 |
| 62 | positive regulation of lymphocyte migration (GO:2000403) | 2.84919702 |
| 63 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.83323154 |
| 64 | response to interferon-beta (GO:0035456) | 2.83152676 |
| 65 | cellular response to interleukin-15 (GO:0071350) | 2.81908004 |
| 66 | negative T cell selection (GO:0043383) | 2.81725794 |
| 67 | cytolysis (GO:0019835) | 2.79899932 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.79740584 |
| 69 | adaptation of signaling pathway (GO:0023058) | 2.75687444 |
| 70 | regulation of cell killing (GO:0031341) | 2.74215514 |
| 71 | positive regulation of tolerance induction (GO:0002645) | 2.73655294 |
| 72 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.70758052 |
| 73 | ATP synthesis coupled proton transport (GO:0015986) | 2.70546096 |
| 74 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.70546096 |
| 75 | neutrophil activation involved in immune response (GO:0002283) | 2.69597134 |
| 76 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.68365118 |
| 77 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.66905550 |
| 78 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.64765441 |
| 79 | positive regulation of T cell chemotaxis (GO:0010820) | 2.63685664 |
| 80 | regulation of T cell chemotaxis (GO:0010819) | 2.63685664 |
| 81 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.61967787 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.60022418 |
| 83 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.60020841 |
| 84 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.58560716 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.58069419 |
| 86 | lymphocyte chemotaxis (GO:0048247) | 2.57577087 |
| 87 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.54193786 |
| 88 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.54193786 |
| 89 | regulation of calcium-mediated signaling (GO:0050848) | 2.54105296 |
| 90 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.53402162 |
| 91 | regulation of lymphocyte apoptotic process (GO:0070228) | 2.53371901 |
| 92 | regulation of mononuclear cell migration (GO:0071675) | 2.51417012 |
| 93 | mast cell activation involved in immune response (GO:0002279) | 2.50533551 |
| 94 | mast cell degranulation (GO:0043303) | 2.50533551 |
| 95 | negative regulation of mast cell activation (GO:0033004) | 2.50513090 |
| 96 | electron transport chain (GO:0022900) | 2.49863645 |
| 97 | respiratory electron transport chain (GO:0022904) | 2.49628405 |
| 98 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.48730131 |
| 99 | regulation of B cell differentiation (GO:0045577) | 2.47710462 |
| 100 | mannosylation (GO:0097502) | 2.47557625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.33148702 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21723041 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.07228942 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.38302955 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05737527 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.94422723 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.93675678 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86716651 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.85715755 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.81210949 |
| 11 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.68043195 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.47855016 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.44952156 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.22289179 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.06903625 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.05061435 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.90619412 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85171757 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80016578 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72290308 |
| 21 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.69691688 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68892550 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65666851 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65510982 |
| 25 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64525922 |
| 26 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62161978 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60414230 |
| 28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.49640134 |
| 29 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49175390 |
| 30 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.49128451 |
| 31 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.48809660 |
| 32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.46881362 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42835283 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41633020 |
| 35 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.39843140 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39061806 |
| 37 | AR_20517297_ChIP-Seq_VCAP_Human | 1.38329174 |
| 38 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.38229001 |
| 39 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.34701181 |
| 40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33212248 |
| 41 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31742363 |
| 42 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.29637277 |
| 43 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.28592829 |
| 44 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.28592829 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27562559 |
| 46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27552488 |
| 47 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.25669005 |
| 48 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.25082586 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24385022 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23229151 |
| 51 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.22620917 |
| 52 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.22620917 |
| 53 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.21952339 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21056392 |
| 55 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.20769574 |
| 56 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20681236 |
| 57 | MYB_26560356_Chip-Seq_TH1_Human | 1.20153585 |
| 58 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19376145 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19074728 |
| 60 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.16006501 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14597211 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13747452 |
| 63 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12769055 |
| 64 | NCOR_22424771_ChIP-Seq_293T_Human | 1.12016132 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10991080 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09788573 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07493114 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06747050 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05978395 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03695556 |
| 71 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03456989 |
| 72 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03202646 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02401358 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.01445615 |
| 75 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.01433953 |
| 76 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.00971986 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00112151 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99891805 |
| 79 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98781440 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98414090 |
| 81 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.96068424 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94589328 |
| 83 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94487384 |
| 84 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93977229 |
| 85 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93870788 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93442600 |
| 87 | P300_27268052_Chip-Seq_Bcells_Human | 0.92780854 |
| 88 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.90758985 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90201553 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89898850 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89170010 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88917537 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88429317 |
| 94 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88333916 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.87620504 |
| 96 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.87207077 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87098663 |
| 98 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85957308 |
| 99 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85868666 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85533360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.23961542 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.36648654 |
| 3 | MP0009785_altered_susceptibility_to | 3.28624245 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 2.99600059 |
| 5 | MP0005464_abnormal_platelet_physiology | 2.93952853 |
| 6 | MP0003724_increased_susceptibility_to | 2.61446783 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.57905815 |
| 8 | MP0003646_muscle_fatigue | 2.48447034 |
| 9 | MP0001800_abnormal_humoral_immune | 2.27091730 |
| 10 | MP0006082_CNS_inflammation | 2.26819117 |
| 11 | MP0002723_abnormal_immune_serum | 2.19021217 |
| 12 | MP0005025_abnormal_response_to | 2.18340383 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.13471753 |
| 14 | MP0002102_abnormal_ear_morphology | 2.09099603 |
| 15 | MP0009764_decreased_sensitivity_to | 2.04035058 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.03682695 |
| 17 | MP0004147_increased_porphyrin_level | 1.99000391 |
| 18 | MP0001819_abnormal_immune_cell | 1.98992349 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.96441256 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.95302209 |
| 21 | MP0003763_abnormal_thymus_physiology | 1.92985432 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.92191909 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.88305972 |
| 24 | MP0001790_abnormal_immune_system | 1.80469608 |
| 25 | MP0005387_immune_system_phenotype | 1.80469608 |
| 26 | MP0003866_abnormal_defecation | 1.79782766 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.77981341 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.62492336 |
| 29 | MP0003436_decreased_susceptibility_to | 1.59868776 |
| 30 | MP0000685_abnormal_immune_system | 1.59737100 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.56330116 |
| 32 | MP0002419_abnormal_innate_immunity | 1.56324222 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.55138145 |
| 34 | MP0000716_abnormal_immune_system | 1.54823517 |
| 35 | MP0002398_abnormal_bone_marrow | 1.52621782 |
| 36 | MP0005410_abnormal_fertilization | 1.51121320 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.50245197 |
| 38 | MP0001873_stomach_inflammation | 1.46089738 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.41358961 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.35229530 |
| 41 | MP0002736_abnormal_nociception_after | 1.32284658 |
| 42 | MP0008872_abnormal_physiological_respon | 1.31824478 |
| 43 | MP0008004_abnormal_stomach_pH | 1.31818711 |
| 44 | MP0002405_respiratory_system_inflammati | 1.30861821 |
| 45 | MP0005083_abnormal_biliary_tract | 1.29074821 |
| 46 | MP0009763_increased_sensitivity_to | 1.24740941 |
| 47 | MP0008469_abnormal_protein_level | 1.23747075 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.22320338 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.22082807 |
| 50 | MP0002429_abnormal_blood_cell | 1.21963927 |
| 51 | MP0002722_abnormal_immune_system | 1.21089466 |
| 52 | MP0003045_fibrosis | 1.14778877 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.14283986 |
| 54 | MP0001919_abnormal_reproductive_system | 1.13315271 |
| 55 | MP0003011_delayed_dark_adaptation | 1.08134599 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.06988852 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.06541281 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.04661267 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 1.02970802 |
| 60 | MP0005389_reproductive_system_phenotype | 1.02936568 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02650737 |
| 62 | MP0006276_abnormal_autonomic_nervous | 0.99845552 |
| 63 | MP0005377_hearing/vestibular/ear_phenot | 0.99840385 |
| 64 | MP0003878_abnormal_ear_physiology | 0.99840385 |
| 65 | MP0002006_tumorigenesis | 0.99766398 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 0.98737512 |
| 67 | MP0002095_abnormal_skin_pigmentation | 0.98145643 |
| 68 | MP0003448_altered_tumor_morphology | 0.97838075 |
| 69 | MP0001968_abnormal_touch/_nociception | 0.97382364 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.95971904 |
| 71 | MP0003075_altered_response_to | 0.95378391 |
| 72 | MP0005360_urolithiasis | 0.92827935 |
| 73 | MP0001905_abnormal_dopamine_level | 0.92303367 |
| 74 | MP0000343_altered_response_to | 0.91545289 |
| 75 | MP0005166_decreased_susceptibility_to | 0.90586853 |
| 76 | MP0000703_abnormal_thymus_morphology | 0.89962581 |
| 77 | MP0004947_skin_inflammation | 0.87806580 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.87650736 |
| 79 | MP0006292_abnormal_olfactory_placode | 0.86327652 |
| 80 | MP0002933_joint_inflammation | 0.85831498 |
| 81 | MP0002733_abnormal_thermal_nociception | 0.85709533 |
| 82 | MP0003195_calcinosis | 0.84985653 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.84670508 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.84438627 |
| 85 | MP0001970_abnormal_pain_threshold | 0.80580392 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.80562403 |
| 87 | MP0001764_abnormal_homeostasis | 0.78496187 |
| 88 | MP0004142_abnormal_muscle_tone | 0.78062782 |
| 89 | MP0005253_abnormal_eye_physiology | 0.77441136 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.77071145 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.75950917 |
| 92 | MP0008877_abnormal_DNA_methylation | 0.75619700 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.75257938 |
| 94 | MP0003136_yellow_coat_color | 0.74671883 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.73734147 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.73382473 |
| 97 | MP0002653_abnormal_ependyma_morphology | 0.72074781 |
| 98 | MP0000858_altered_metastatic_potential | 0.71685161 |
| 99 | MP0001542_abnormal_bone_strength | 0.71662734 |
| 100 | MP0003137_abnormal_impulse_conducting | 0.71363273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.47024599 |
| 2 | T lymphocytopenia (HP:0005403) | 4.08710831 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.00895474 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.89681342 |
| 5 | IgG deficiency (HP:0004315) | 3.88976531 |
| 6 | Hypoproteinemia (HP:0003075) | 3.61569043 |
| 7 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.41051757 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.35361350 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.34316625 |
| 10 | Increased intramyocellular lipid droplets (HP:0012240) | 3.32472121 |
| 11 | Congenital stationary night blindness (HP:0007642) | 3.27958857 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.23372394 |
| 13 | Decreased central vision (HP:0007663) | 3.19438642 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.19372646 |
| 15 | Abnormality of the prostate (HP:0008775) | 3.14447234 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.14313397 |
| 17 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.13965485 |
| 18 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.13965485 |
| 19 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.07518111 |
| 20 | Stomatitis (HP:0010280) | 3.07421172 |
| 21 | Autoimmune hemolytic anemia (HP:0001890) | 3.04799883 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.02041308 |
| 23 | Increased IgM level (HP:0003496) | 2.98636828 |
| 24 | Hepatic necrosis (HP:0002605) | 2.81723480 |
| 25 | Petechiae (HP:0000967) | 2.80810599 |
| 26 | Abolished electroretinogram (ERG) (HP:0000550) | 2.79872186 |
| 27 | Abnormality of B cell number (HP:0010975) | 2.77422003 |
| 28 | Increased CSF lactate (HP:0002490) | 2.76030815 |
| 29 | Acute encephalopathy (HP:0006846) | 2.72942441 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.71180756 |
| 31 | Progressive macrocephaly (HP:0004481) | 2.67290874 |
| 32 | Abnormality of T cells (HP:0002843) | 2.65491599 |
| 33 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.62766011 |
| 34 | Chronic diarrhea (HP:0002028) | 2.62408809 |
| 35 | Renal Fanconi syndrome (HP:0001994) | 2.56129853 |
| 36 | Pancreatic cysts (HP:0001737) | 2.50447517 |
| 37 | Attenuation of retinal blood vessels (HP:0007843) | 2.47000717 |
| 38 | Thyroiditis (HP:0100646) | 2.46280996 |
| 39 | Generalized aminoaciduria (HP:0002909) | 2.44291521 |
| 40 | Molar tooth sign on MRI (HP:0002419) | 2.44153881 |
| 41 | Abnormality of midbrain morphology (HP:0002418) | 2.44153881 |
| 42 | Encephalitis (HP:0002383) | 2.42681579 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.41613323 |
| 44 | Prolonged bleeding time (HP:0003010) | 2.40223612 |
| 45 | B lymphocytopenia (HP:0010976) | 2.38557519 |
| 46 | Abnormality of eosinophils (HP:0001879) | 2.38270751 |
| 47 | Purpura (HP:0000979) | 2.37805091 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37721940 |
| 49 | Abnormality of macrophages (HP:0004311) | 2.34422037 |
| 50 | Cerebral edema (HP:0002181) | 2.33650538 |
| 51 | True hermaphroditism (HP:0010459) | 2.31102714 |
| 52 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.27764919 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26566761 |
| 54 | Obstructive lung disease (HP:0006536) | 2.26566761 |
| 55 | Epistaxis (HP:0000421) | 2.26132079 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.22573694 |
| 57 | Increased serum lactate (HP:0002151) | 2.17331249 |
| 58 | Abnormality of alanine metabolism (HP:0010916) | 2.16545344 |
| 59 | Hyperalaninemia (HP:0003348) | 2.16545344 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.16545344 |
| 61 | Gangrene (HP:0100758) | 2.13860570 |
| 62 | Abnormal albumin level (HP:0012116) | 2.13372839 |
| 63 | Hypoalbuminemia (HP:0003073) | 2.13372839 |
| 64 | Leukocytosis (HP:0001974) | 2.11752652 |
| 65 | Lipid accumulation in hepatocytes (HP:0006561) | 2.10643019 |
| 66 | Exertional dyspnea (HP:0002875) | 2.08511073 |
| 67 | Pancreatic fibrosis (HP:0100732) | 2.07768753 |
| 68 | Lactic acidosis (HP:0003128) | 2.06659125 |
| 69 | Constricted visual fields (HP:0001133) | 2.06278644 |
| 70 | Type 2 muscle fiber atrophy (HP:0003554) | 2.05320722 |
| 71 | Severe visual impairment (HP:0001141) | 2.05250575 |
| 72 | Optic disc pallor (HP:0000543) | 2.04077088 |
| 73 | Type I transferrin isoform profile (HP:0003642) | 2.02920118 |
| 74 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00857339 |
| 75 | Eosinophilia (HP:0001880) | 1.99740943 |
| 76 | Lymphopenia (HP:0001888) | 1.99598332 |
| 77 | Chest pain (HP:0100749) | 1.98986158 |
| 78 | Pancytopenia (HP:0001876) | 1.96605031 |
| 79 | Vasculitis (HP:0002633) | 1.95389151 |
| 80 | Meningitis (HP:0001287) | 1.95182124 |
| 81 | Myositis (HP:0100614) | 1.93982541 |
| 82 | Gingival bleeding (HP:0000225) | 1.93746115 |
| 83 | Type II lissencephaly (HP:0007260) | 1.93099744 |
| 84 | Abnormality of the renal cortex (HP:0011035) | 1.85122292 |
| 85 | Pustule (HP:0200039) | 1.84271024 |
| 86 | Retrobulbar optic neuritis (HP:0100654) | 1.83072562 |
| 87 | Optic neuritis (HP:0100653) | 1.83072562 |
| 88 | Hemoptysis (HP:0002105) | 1.82341121 |
| 89 | Joint swelling (HP:0001386) | 1.82302760 |
| 90 | Muscle fiber atrophy (HP:0100295) | 1.82229279 |
| 91 | Lethargy (HP:0001254) | 1.80925981 |
| 92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80668134 |
| 93 | Abnormal drinking behavior (HP:0030082) | 1.79585071 |
| 94 | Polydipsia (HP:0001959) | 1.79585071 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 1.79179378 |
| 96 | Retinal dysplasia (HP:0007973) | 1.75972851 |
| 97 | Cerebral palsy (HP:0100021) | 1.74265962 |
| 98 | Abnormality of magnesium homeostasis (HP:0004921) | 1.74204016 |
| 99 | Hypomagnesemia (HP:0002917) | 1.73073553 |
| 100 | Panhypogammaglobulinemia (HP:0003139) | 1.72027653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.40443226 |
| 2 | KDR | 4.20359029 |
| 3 | TESK2 | 3.89869315 |
| 4 | BCKDK | 3.22414523 |
| 5 | ZAK | 3.16678508 |
| 6 | TAOK3 | 3.00991074 |
| 7 | TLK1 | 2.55382785 |
| 8 | ADRBK2 | 2.35668049 |
| 9 | MST4 | 2.03305021 |
| 10 | MAP4K2 | 1.93334973 |
| 11 | MAP4K1 | 1.92742279 |
| 12 | ITK | 1.91267346 |
| 13 | TEC | 1.89333445 |
| 14 | SYK | 1.84043616 |
| 15 | GRK1 | 1.75047095 |
| 16 | NUAK1 | 1.72275691 |
| 17 | GRK7 | 1.71057384 |
| 18 | FES | 1.64004196 |
| 19 | BMPR2 | 1.63893171 |
| 20 | MAP3K12 | 1.61573854 |
| 21 | CDK19 | 1.55040294 |
| 22 | LIMK1 | 1.53275164 |
| 23 | PIM2 | 1.48240127 |
| 24 | BTK | 1.47066572 |
| 25 | GRK6 | 1.41994522 |
| 26 | PINK1 | 1.37306632 |
| 27 | FRK | 1.35366864 |
| 28 | MAP3K11 | 1.32054573 |
| 29 | TESK1 | 1.24901226 |
| 30 | KIT | 1.23538283 |
| 31 | IKBKB | 1.22338739 |
| 32 | RIPK4 | 1.21396762 |
| 33 | MAPKAPK3 | 1.18021110 |
| 34 | STK16 | 1.17463791 |
| 35 | EIF2AK1 | 1.14268753 |
| 36 | PRKCQ | 1.13103143 |
| 37 | TIE1 | 1.12468197 |
| 38 | MYLK | 1.11464774 |
| 39 | CSK | 1.09196964 |
| 40 | LYN | 1.08925045 |
| 41 | MATK | 1.07362007 |
| 42 | VRK2 | 1.07330227 |
| 43 | SCYL2 | 1.05270483 |
| 44 | LCK | 1.03198229 |
| 45 | TNK2 | 1.02553184 |
| 46 | CSF1R | 1.01821357 |
| 47 | ZAP70 | 0.97148122 |
| 48 | VRK1 | 0.91984956 |
| 49 | MUSK | 0.90767977 |
| 50 | JAK3 | 0.89749879 |
| 51 | CSNK1G3 | 0.81807046 |
| 52 | BMPR1B | 0.81085554 |
| 53 | TBK1 | 0.79735256 |
| 54 | IKBKE | 0.79430232 |
| 55 | WNK3 | 0.78574614 |
| 56 | DAPK1 | 0.78218726 |
| 57 | GRK5 | 0.77417084 |
| 58 | ACVR1B | 0.75504610 |
| 59 | WNK4 | 0.73294069 |
| 60 | RPS6KA5 | 0.71649964 |
| 61 | PIM1 | 0.71575297 |
| 62 | PIK3CG | 0.70808447 |
| 63 | ADRBK1 | 0.70628486 |
| 64 | INSRR | 0.67671108 |
| 65 | MAP2K7 | 0.67619092 |
| 66 | DAPK2 | 0.65019473 |
| 67 | CSNK1A1L | 0.61881858 |
| 68 | CSNK1G1 | 0.58584405 |
| 69 | CSNK1G2 | 0.55651335 |
| 70 | OXSR1 | 0.54600260 |
| 71 | MAP3K5 | 0.52104500 |
| 72 | TYRO3 | 0.50790157 |
| 73 | DAPK3 | 0.50203980 |
| 74 | MAPK13 | 0.49313114 |
| 75 | PAK1 | 0.48282975 |
| 76 | PRKCA | 0.47092715 |
| 77 | EIF2AK3 | 0.47028336 |
| 78 | IGF1R | 0.46574186 |
| 79 | PLK2 | 0.46450429 |
| 80 | FYN | 0.46213484 |
| 81 | TRIM28 | 0.44552878 |
| 82 | CAMKK2 | 0.43837220 |
| 83 | PIK3CA | 0.43424451 |
| 84 | RPS6KA4 | 0.41689743 |
| 85 | ARAF | 0.40352745 |
| 86 | MARK3 | 0.38826541 |
| 87 | HCK | 0.38446651 |
| 88 | PRKACA | 0.37317623 |
| 89 | PTK2B | 0.36819734 |
| 90 | ROCK1 | 0.34744028 |
| 91 | PRKCD | 0.33253148 |
| 92 | FGR | 0.33119005 |
| 93 | MAP3K3 | 0.32924381 |
| 94 | ABL1 | 0.32654523 |
| 95 | DYRK2 | 0.32438739 |
| 96 | AURKA | 0.30909869 |
| 97 | CAMK2A | 0.30049845 |
| 98 | INSR | 0.29819487 |
| 99 | BMX | 0.28292350 |
| 100 | MAP2K6 | 0.27873937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.04354846 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.95007635 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.66799891 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.59440280 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.18506042 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.98310338 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.94979084 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.94761430 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.65696595 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.60827227 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.54331420 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.43504002 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17012689 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.09069440 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 1.77070815 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75735327 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64474261 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58736727 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.58139017 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55403832 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.39890698 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37805594 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34447136 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.33922091 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.33731699 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30505269 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28757305 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26927991 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23220470 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22298804 |
| 31 | RNA polymerase_Homo sapiens_hsa03020 | 1.07284336 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.04950482 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.03585421 |
| 34 | Ribosome_Homo sapiens_hsa03010 | 1.03427333 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.03301755 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98523886 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97240471 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97172601 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96491163 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96079017 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94021730 |
| 42 | Protein export_Homo sapiens_hsa03060 | 0.92677101 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.91486729 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87687942 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.86025168 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84650283 |
| 47 | Measles_Homo sapiens_hsa05162 | 0.82061031 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78192454 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.77449600 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72674833 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71300932 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70927246 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70371421 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68340651 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65717503 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65528046 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65371507 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64795384 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64776901 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.63782051 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63624549 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61675464 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60672173 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57264590 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56241662 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.54221470 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54152539 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53686635 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53626375 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 0.53029498 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.52259243 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51640510 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49508399 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48990319 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.48340955 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47871933 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44627100 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.43253367 |
| 79 | Purine metabolism_Homo sapiens_hsa00230 | 0.42610444 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39745923 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.37628212 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32694930 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32152942 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.32120187 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31495197 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.31037983 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.30200750 |
| 88 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30117097 |
| 89 | RNA degradation_Homo sapiens_hsa03018 | 0.29963723 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29590702 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29193666 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28892634 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.28584034 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28009887 |
| 95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27405716 |
| 96 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.26850968 |
| 97 | Taste transduction_Homo sapiens_hsa04742 | 0.26808915 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24493835 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24220671 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23204211 |

